Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Clinterooon Sep 23, 2013 4:53pm

137 Views

Post# 21761119

RE:RE:insiders

Ruffio, just so everyone is clear they are not buying anything over $0.15. The warrants that show a price of $0.16 are included in the shares they purchase at $0.12. So they are buying 200,000 shares at $0.12 and are given an option to buy more later at $0.16. Obviously if the price is above $0.16 in a year or so they will exercise. If not, then they wont exercise.

It is still good that they are putting in about $25,000 each so I am not saying anything negative just clariying your post about it being good that they buy above $0.15.

Bullboard Posts

Eminent acquires promising Nevada gold project